Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
[DOI] [PubMed] [Google Scholar] 86.Neal B, Perkovic V, Mahaffey KW, et al
Regulatory Notice: Many peptides are for research use only and may not be FDA-approved for human use
My member ID is [NUMBER]
59(Suppl 2): 3-5
GLP-1 receptor agonists in pediatric and adolescent obesity
The secondary outcomes (all-cause mortality and cardiovascular composite event outcome) and post-hoc outcomes (combined kidney outcome and safety outcomes) were compared using logistic regression analysis, in which the outcome of interest was the dependent variable and use of GLP-RA or DDP41 as independent variable
US$ 22.52
US$ 29.83
US$ 23.56
US$ 28.15
US$ 29.22
US$ 27.50
